Detalles de la búsqueda
1.
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
N Engl J Med
; 388(15): 1353-1364, 2023 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36876740
2.
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study.
Diabetes Obes Metab
; 26(6): 2412-2421, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38558508
3.
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.
JAMA
; 331(1): 38-48, 2024 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38078870
4.
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.
N Engl J Med
; 380(11): 1022-1032, 2019 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30865796
5.
Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials.
Diabetes Obes Metab
; 24(5): 868-880, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34981622
6.
Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance.
Am Heart J
; 235: 104-112, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33470195
7.
Role of Bempedoic Acid in Clinical Practice.
Cardiovasc Drugs Ther
; 35(4): 853-864, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33818688
8.
Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study.
Diabetologia
; 62(6): 948-958, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30953107
9.
Correction to: Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials.
Cardiovasc Drugs Ther
; 32(2): 181, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29713852
10.
Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials.
Cardiovasc Drugs Ther
; 32(2): 175-180, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29627892
11.
Icosapent ethyl: Eicosapentaenoic acid concentration and triglyceride-lowering effects across clinical studies.
Prostaglandins Other Lipid Mediat
; 125: 57-64, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27418543
12.
Icosabutate, a Structurally Engineered Fatty Acid, Improves the Cardiovascular Risk Profile in Statin-Treated Patients with Residual Hypertriglyceridemia.
Cardiology
; 135(1): 3-12, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27160246
13.
Correction to: Role of Bempedoic Acid in Clinical Practice.
Cardiovasc Drugs Ther
; 35(4): 865, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33871715
14.
Alirocumab, Decreased Mortality, Nominal Significance, P Values, Bayesian Statistics, and the Duplicity of Multiplicity.
Circulation
; 140(2): 113-116, 2019 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31283369
15.
Adiposopathy, "sick fat," Ockham's razor, and resolution of the obesity paradox.
Curr Atheroscler Rep
; 16(5): 409, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24659222
16.
Colesevelam, Ezetimibe, and Patients With Type 2 Diabetes Mellitus: Characteristics and Clinical Outcomes From a Health Care Database.
Ann Pharmacother
; 48(7): 847-855, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24740470
17.
Corrigendum to "Obesity pillars roundtable: Body mass index and body composition in black and female individuals. Race-relevant or racist? Sex-relevant or sexist?" [Obesity Pillars 4C (2022) 100044].
Obes Pillars
; 10: 100105, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38774294
18.
Effects of phentermine / topiramate extended-release, phentermine, and placebo on ambulatory blood pressure monitoring in adults with overweight or obesity: A randomized, multicenter, double-blind study.
Obes Pillars
; 9: 100099, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38304225
19.
Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance.
J Clin Lipidol
; 18(1): e59-e69, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37951797
20.
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024.
J Clin Lipidol
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38664184